Zobrazeno 1 - 10
of 304
pro vyhledávání: '"Ryan, Wilcox"'
Autor:
Carlos Murga-Zamalloa, Shaun Webb, John Reneau, Alejandro Zevallos, Pierina Danos-Diaz, Vanessa Perez-Silos, Mirna Rodriguez, Guangyao Gao, Wolf-Nicolas Fischer, Bernd Jandeleit, Ryan Wilcox
Publikováno v:
Leukemia Research Reports, Vol 21, Iss , Pp 100398- (2024)
T-cell lymphomas are aggressive neoplasms characterized by poor responses to current chemotherapeutic agents. Expression of the l-type amino acid transporter 1 (LAT 1, SLC7A5) allows for the expansion of healthy T-cell counterparts, and upregulation
Externí odkaz:
https://doaj.org/article/8998a2e3b96f4b23b775c3aba7f40590
Autor:
Yuka Torii, Kana Nanjo, Tomomi Toubai, Masashi Hosokawa, Ryo Sato, Akane Yamada, Keiko Aizawa, Masahito Himuro, Satoshi Ito, Masakazu Yamamoto, John Magenau, Ryan Wilcox, Kenichi Ishizawa
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-6 (2021)
Abstract Background Chronic myeloid leukemia is a hematologic malignancy associated with the fusion of two genes: BCR and ABL1. This fusion results from a translocation between chromosomes 9 and 22, which is called the Philadelphia chromosome. Althou
Externí odkaz:
https://doaj.org/article/96e8a34788454a97baa4b4773d89fcf7
Autor:
Taylor Novice, BS, Ji Won Ahn, MD, Ryan Wilcox, MD, PHD, Trilokraj Tejasvi, MBBS, Alexandra Hristov, MD, Jennifer Mancuso, MD
Publikováno v:
JAAD Case Reports, Vol 6, Iss 4, Pp 311-315 (2020)
Externí odkaz:
https://doaj.org/article/c5673d3ffccc4b459ba95f8df0253dbb
Autor:
Yuka Torii, Kana Nanjo, Tomomi Toubai, Masashi Hosokawa, Ryo Sato, Akane Yamada, Keiko Aizawa, Masahito Himuro, Satoshi Ito, Masakazu Yamamoto, John Magenau, Ryan Wilcox, Kenichi Ishizawa
Publikováno v:
Kompass Onkologie. 10:46-49
Hintergrund: Die chronische myeloische Leukämie ist eine hämatologische Malignität, die mit der Fusion von zwei Genen einhergeht: BCR und ABL1. Diese Fusion resultiert aus einer Translokation zwischen den Chromosomen 9 und 22, auch als Philadelphi
Autor:
Steven M. Horwitz, Stephen Ansell, Weiyun Z. Ai, Jeffrey Barnes, Stefan K. Barta, Jonathan Brammer, Mark W. Clemens, Ahmet Dogan, Francine Foss, Paola Ghione, Aaron M. Goodman, Joan Guitart, Ahmad Halwani, Bradley M. Haverkos, Richard T. Hoppe, Eric Jacobsen, Deepa Jagadeesh, Allison Jones, Avyakta Kallam, Youn H. Kim, Kiran Kumar, Neha Mehta-Shah, Elise A. Olsen, Saurabh A. Rajguru, Sima Rozati, Jonathan Said, Aaron Shaver, Lauren Shea, Michi M. Shinohara, Lubomir Sokol, Carlos Torres-Cabala, Ryan Wilcox, Peggy Wu, Jasmine Zain, Mary Dwyer, Hema Sundar
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:285-308
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioi
Autor:
Ryan Wilcox
Publikováno v:
Journal of Agricultural and Environmental Ethics. 35
Autor:
Adam L Cohen, Raffaella Soldi, Haiyu Zhang, Adam M Gustafson, Ryan Wilcox, Bryan E Welm, Jeffrey T Chang, Evan Johnson, Avrum Spira, Stefanie S Jeffrey, Andrea H Bild
Publikováno v:
Molecular Systems Biology, Vol 7, Iss 1, Pp 1-13 (2011)
Abstract Identifying the best drug for each cancer patient requires an efficient individualized strategy. We present MATCH (Merging genomic and pharmacologic Analyses for Therapy CHoice), an approach using public genomic resources and drug testing of
Externí odkaz:
https://doaj.org/article/1741f4b3bdb943c39a39dfea025050ae
Autor:
Thomas, Jason jthomas@scbiznews.com
Publikováno v:
Charleston Regional Business Journal. 6/17/2024, Vol. 30 Issue 9, p42-42. 1/4p.
Autor:
Jennifer, Girard, Yasmin, Karimi, Shannon, Carty, Ryan, Wilcox, Mark, Kaminiski, Sami, Malek, Tycel, Phillips
Publikováno v:
Current hematologic malignancy reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 16(1)
Follicular lymphoma (FL) is the 2nd most common lymphoma in the USA/Western Europe. While incurable, the majority of patients are able to survive at least a decade with this disease. Response duration though varies, and subset of patients will relaps
Autor:
Neha, Mehta-Shah, Steven M, Horwitz, Stephen, Ansell, Weiyun Z, Ai, Jeffrey, Barnes, Stefan K, Barta, Mark W, Clemens, Ahmet, Dogan, Kristopher, Fisher, Aaron M, Goodman, Gaurav, Goyal, Joan, Guitart, Ahmad, Halwani, Bradley M, Haverkos, Richard T, Hoppe, Eric, Jacobsen, Deepa, Jagadeesh, Matthew A, Lunning, Amitkumar, Mehta, Elise A, Olsen, Barbara, Pro, Saurabh A, Rajguru, Satish, Shanbhag, Aaron, Shaver, Andrei, Shustov, Lubomir, Sokol, Pallawi, Torka, Carlos, Torres-Cabala, Ryan, Wilcox, Basem M, William, Jasmine, Zain, Mary A, Dwyer, Hema, Sundar, Youn H, Kim
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 18(5)
Mycosis fungoides (MF) is the most common subtype of cutaneous T-cell lymphoma (CTCL), and Sézary syndrome (SS) is a rare erythrodermic and leukemic subtype of CTCL characterized by significant blood involvement. Although early-stage disease can be